Elimination of various subpopulations of macrophages and the development of multiple-organ dysfunction syndrome in mice

Archives of Surgery

Volumn 132, Issue 5, 1997, Pages 533-539

  Nieuwenhuijzen, Grard A P ^a,c   Knapen, Maarten F C M ^a   Hendriks, Thijs ^a   Van Rooijen, Nico ^b   Goris, R Jan A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c CPRLab   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; LIPOSOME; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL SUBPOPULATION; MACROPHAGE FUNCTION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; TEMPERATURE MEASUREMENT;

EID: 0030979711     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430290079016     Document Type: Article

References (40)

1. Goris RJA, te Boekhorst TPA, Nuytinck JKS, Gimbrere JSF. Multiple organ failure: generalized autodestructive inflammation? Arch Surg. 1985;120:1109-1115.
2. Baue AE. The horror autotoxicus and multiple-organ failure. Arch Surg. 1992; 127:1451-1462.
3. Johnston RB. Monocytes and macrophages. N Engl J Med. 1988;318:747-752.
4. Beal AL, Cerra FB. Multiple organ failure in the 1990s: systemic inflammatory response and organ dysfunction. JAMA. 1994;271:226-233.
5. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg. 1992;216:117-134.
6. Border JR. Sepsis, multiple systems organ failure, and the macrophage. Arch Surg. 1988;123:285-286.
7. Butler LD, Layman NK, Cain RL, et al. Interleukin 1-induced pathophysioiogy: induction of cytokines, development of histopathological changes, and immunopharmacologic intervention. Clin Immunol Immunopathol. 1989;53:400-412.
8. Tracey KJ, Beutler B, Lowry SF. Shock and tissue injury induced by recombinant human cachectin. Science. 1986;234:470-474.
9. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest. 1993;103:565-575.
10. Roumen RMH, Hendriks T, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe trauma. Ann Surg. 1993;218:769-776.
11. Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/ tumor necrosis factor protects from the lethal effects of endotoxin. Science. 1985;229:869-871.
12. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC. lnterleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990; 348:550-552.
13. Starnes HF, Pearce MK, Tewari A, Yim JH, Zou JC, Abrams JS. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor alpha challenge in mice. J Immunol. 1990;145:4185-4191.
14. Goya T, Abe M, Shimura H, Torisu M. Characteristics of alveolar macrophages in experimental septic lung. J Leukoc Biol. 1992;52:236-243.
15. Suter PM, Suter S, Girardin E, Roux LP, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, Interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992;145:1016-1022.
16. Billiar TR, Curran RD. Kupffer cell and hepatocyte interactions: a brief overview. JPEN J Parenter Enterai Nutr. 1990;14:175S-180S.
17. Marshall JC, Lee C, Meakins JL, Michel RP, Christou NV. Kupffer cell modulation of the systemic immune response. Arch Surg. 1987;122:191-196.
18. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH. The complex pattern of cytokines in sepsis: association between prostaglandins. cachectin, and interleukins. Ann Surg. 1991;214:141-148.
19. O'Riordain M, Collins K, Pilz M, Saporoschetz I, Mannick J, Rodrick M. Modulation of macrophage hyperactivity improves survival in a burn sepsis model. Arch Surg. 1992;127:152-158.
20. McMasters KM, Cheadle WG. Regulation of macrophage TNF-α, IL-1β and l-Aα mRNA expression during peritonitis is site dependent. J Surg Res. 1993;54: 426-430.
21. Jansen MJJM, Hendriks T, Vogels MT, van der Meer JWM, Goris RJA. Inflammatory cytokines in an experimental model for multiple organ dysfunction syndrome. Crit Care Med. 1996;24:1196-1202.
22. van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83-93.
23. Qian Q, Jutila MA, van Rooijen N, Cutler JE. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol. 1994;152:5000-5008.
24. Goris RJA, Boekholtz WKF, van Bebber IPT, Nuytinck JKS, Schillings PHM. Multipleorgan failure and sepsis without bacteria. Arch Surg. 1986;121:897-901.
25. Mainous M, Tso P, Berg RD, Deitch EA. Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation. Arch Surg. 1991;126:33-37.
26. Nieuwenhuijzen GAP, Haskel Y, Lu Q, et al. Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation. Ann Surg. 1993;218:791-799.
27. Thepen T, van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med. 1989;170:199-208.
28. Biewenga J, van de Ende MB, Krist LFG, Borst A, Gufron M, van Rooijen N. Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant. Cell Tissue Res. 1995;280:189-196.
29. Koziol JA, Maxwell DA, Fukushima M, Colmerauer MEM, Pilch YH. A distribution-free test for tumor-growth curve analysis with application to an animal tumor immunotherapy experiment. Biometrics. 1981;37:383-390.
30. Gallery MP, Kamei T, Mangino MJ, Flye W. Organ interactions in sepsis: host defense and the hepatic-pulmonary macrophage axis. Arch Surg. 1991;126:28-32.
31. Gallery MP, Kamei T, Flye W. Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. Arch Surg. 1990; 125:36-41.
32. Hardonk MJ, Dijkhuis FW, Hulstaert CE, Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and re-population. J Leukoc Biol. 1992;52:296-302.
33. van Rooijen N, van Nieuwmegen R, Kamperdijk EWA. Elimination of phagocytic cells in the spleen after intravenous injection of liposome encapsulated dichloromethylene diphosphonate: ultrastructural aspects of elimination of marginal zone macrophages. Virchows Arch. 1985;49:375-383.
34. Wichterman K, Baue A, Chaudry I. Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res. 1980;29:189-201.
35. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH. Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor). Circ Shock. 1992;36:191-199.
36. Stephan RN, Ayala A, Harkema JM, Dean RE, Border JR, Chaudry IH. Mechanism of immunosuppression following hemorrhage: defective antigen presentation by macrophages. J Surg Res. 1989;46:553-556.
37. Ayala A, Perrin MM, Wagner MA, Chaudry IH. Enhanced susceptibility to sepsis after simple hemorrhage: depression of Fc and C3b receptor-mediated phagocytosis. Arch Surg. 1990;125:70-74.
38. Steinberg KP, Milberg JA, Martin TR, Maunder RJ, Cockrill BA, Hudson LD. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Cril Care Med. 1994;150:113-122.
39. Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Force RA. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high risk surgical patients. Ann Surg. 1994;220:601-609.
40. Browder W, Williams D, Pretus H, et al. Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg. 1990;211:605-613.